Provided by Tiger Trade Technology Pte. Ltd.

Maison Solutions

1.56
-0.0550-3.42%
Post-market: 1.560.0090+0.58%19:45 EDT
Volume:82.04K
Turnover:128.92K
Market Cap:1.33M
PE:-0.06
High:1.63
Open:1.59
Low:1.54
Close:1.61
52wk High:57.00
52wk Low:1.24
Shares:855.30K
Float Shares:558.80K
Volume Ratio:0.34
T/O Rate:14.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-26.7021
EPS(LYR):3.35
ROE:-127.03%
ROA:-7.62%
PB:0.17
PE(LYR):0.46

Loading ...

Adagene to Participate in Two Upcoming Investor Conferences

GlobeNewswire
·
May 12

Maison Solutions gets Nasdaq noncompliance notice over missed annual meeting deadline

Reuters
·
May 12

Oncolytics Biotech® Reports Durable Responses in Second-Line RAS-Mutant MSS Colorectal Cancer

GlobeNewswire
·
May 04

Maison Solutions Reaches Derivative Suit Governance Settlement

TIPRANKS
·
Apr 30

Maison Solutions reaches proposed settlement in shareholder derivative lawsuit

Reuters
·
Apr 30

Maison Solutions - to Adopt, Implement & Maintain Some Corporate Governance Reforms for Five Years - SEC Filing

THOMSON REUTERS
·
Apr 30

Maison Solutions Inc - Announces Proposed Settlement of Stockholder Derivative Action - SEC Filing

THOMSON REUTERS
·
Apr 30

Analyst Initiates Buy on Muza Developer, Citing Promising MSS CRC Data, Clear Registrational Path, and Broader Expansion Upside Despite Cash Constraints

TIPRANKS
·
Apr 27

Maison Solutions CEO John Xu reports $2,952 purchase of common shares

Reuters
·
Apr 24

Maison Solutions Inc trading halted, news pending

TIPRANKS
·
Apr 24

Maison Solutions Enacts Reverse Stock Split to Retain Nasdaq Listing

TIPRANKS
·
Apr 22

BRIEF-Maison Solutions To Implement 1-For-10 Reverse Stock Split Effective April 24

Reuters
·
Apr 22

Maison Solutions: Will Implement 1-for-10 Reverse Stock Split of Outstanding Shares of Class a Common Stock, Effective on April 24

THOMSON REUTERS
·
Apr 22

Maison Solutions to execute 1-for-10 reverse stock split April 24

Reuters
·
Apr 22

PDS Biotech Announces Publication of Positive PDS01ADC Interim Phase 2 Clinical Trial Data from Stage 1 of NCI-led Metastatic Colorectal Cancer (mCRC) Trial

GlobeNewswire
·
Apr 15

Maison Solutions Is Maintained at Buy by Ascendiant Capital

Dow Jones
·
Apr 14

Press Release: Adagene Adds Industry Veteran Peter Lebowitz to Scientific and Strategic Advisory Board

Dow Jones
·
Apr 14

Halper Sadeh probes Maison Solutions insiders for potential fiduciary-duty breaches

Reuters
·
Apr 10

Maison Solutions CEO John Xu reports $6,400 common share purchase

Reuters
·
Apr 10